BHC

Bausch Health Companies Inc
NYSE

Real-time Quotes | Nasdaq Last Sale

15.25
+0.74
+5.10%
Closed 17:12 03/30 EDT
OPEN
14.48
PREV CLOSE
14.51
HIGH
15.37
LOW
13.39
VOLUME
6.00M
TURNOVER
--
52 WEEK HIGH
31.97
52 WEEK LOW
11.15
MARKET CAP
5.39B
P/E (TTM)
-3.0073
1D
5D
1M
3M
1Y
5Y

Buy or sell shares of BHC and other stocks commission-free!

Open a Webull account and fund it to get a free stock

Analyst Rating

Based on 5 analysts

Hold

Disclaimer: The analysis information is for reference only and does not constitute an investment recommendation.

Analyst Price Target

The average BHC stock price target is 28.43 with a high estimate of 35.00 and a low estimate of 21.14.

EPS

BHC News

More
  • Bausch Health Companies: Debt, Cash And Goodwill
  • Seeking Alpha - Article · 18h ago
  • Unique Opportunity To Double Dip With Bausch Health
  • Seeking Alpha - Article · 18h ago
  • VRX Investor Alert: Kyros Law is Filing Legal Claims on Behalf of Valeant Pharmaceuticals (NYSE: VRX), now Bausch Health Companies (NYSE: BHC) Investors
  • PR Newswire · 21h ago
  • Bausch Health Donates Health Care Products And Supplies Through Bausch Foundation In Response To COVID-19 Pandemic
  • CNW Group · 6d ago

Industry

Pharmaceuticals
+4.97%
Pharmaceuticals & Medical Research
+4.75%

Hot Stocks

Symbol
Price
%Change

About BHC

Bausch Health Companies Inc, formerly Valeant Pharmaceuticals International Inc, is a Canada-based company that develops, manufactures and markets a range of branded and generic pharmaceuticals, medical devices and over-the-counter products. It primarily develops products in the therapeutic areas of eye health, gastroenterology and dermatology. Its dermatology products treat a range of conditions, including actinic keratosis, acne, atopic dermatitis, psoriasis and other dermatoses. It also offers a selection of aesthetic medical devices that address a variety of conditions, including facial wrinkles, acne, pigmentation conditions and laser hair removal, among others. The gastrointestinal (GI) segment offers products that treat GI and hepatologic conditions, including hepatic encephalopathy, irritable bowel syndrome with diarrhea and ulcerative colitis, among others. Its eye health products are marketed in the following categories: Contact Lens, Pharmaceutical Products and Surgical.
More

Webull offers kinds of Bausch Health Companies Inc stock information, including NYSE:BHC real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, BHC stock news, and many more online research tools to help you make informed decisions.